stockrow
Friday 6 November 2026
Export CLPT’s income statement to Excel — free account
ClearPoint Neuro, Inc.
CLPT Healthcare Medical Devices
ClearPoint Neuro, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $37.0 million, up 17.8% from fiscal 2024.
- Revenue
- +36.3%
- EPS
- −14.7%
- Free cash flow
- −58.1%
- Total debt
- +74.1%
Quarter to September 2026, against a year earlier
8.60
0.09
−1.04%
Follow CLPT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(95.64%) | (149.72%) | (226.52%) | (167.52%) | |
Piotroski F-Score |
4 | 4 | 2 | 4 | |
| (37.30%) | (47.08%) | (46.21%) | (41.75%) | ||
ROIC |
(48.45%) | (50.31%) | (61.31%) | (62.84%) | |
Return on Tangible Assets |
(46.05%) | (60.16%) | (83.08%) | (60.26%) | |
Average Days of Receivables |
64.66 | 77.85 | 72.48 | 64.32 | |
Free Cash Flow per Share |
(0.86) | (0.90) | (1.04) | (1.07) | |
Free Cash Flow |
(24.45) | (26.70) | (31.29) | (33.22) | |
Capital Expenditures |
(0.52) | (0.98) | (1.11) | (1.04) | |
| Other line items | |||||
Cash ROIC |
(19.87%) | (25.66%) | (34.62%) | (26.73%) | |
Accounts Receivable Turnover |
6.57 | 6.60 | 6.68 | 7.57 | |
Accounts Payable Turnover |
11.00 | 8.63 | 8.58 | 19.70 | |
Inventory Turnover |
1.88 | 2.02 | 2.09 | 2.15 | |
Average Days of Payables |
32.11 | 55.59 | 49.71 | 22.03 | |
Days of Inventory on Hand |
213.67 | 204.55 | 203.48 | 203.07 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
37.59% | 37.03% | 37.47% | 36.07% | |
Selling, General and Administrative Expense of Revenue |
89.15% | 90.50% | 98.56% | 95.88% | |
Share Based Compensation of Revenue |
22.13% | 20.90% | 20.09% | 18.35% | |
Interest Coverage |
(9.71) | (7.02) | (6.44) | (6.03) | |
Operating CF/Net income |
0.94 | 0.88 | 0.87 | 0.89 | |
Depreciation/Fixed assets |
0.89 | 1.08 | 1.31 | 1.65 | |
Capex/Depreciation |
(0.22) | (0.31) | (0.28) | (0.20) | |
Revenue per Share |
1.31 | 1.37 | 1.40 | 1.47 | |
Operating CF per Share |
(0.84) | (0.87) | (1.00) | (1.04) | |
Capex per Share |
(0.02) | (0.03) | (0.04) | (0.03) | |
Capex to Sales |
0.01 | 0.02 | 0.03 | 0.02 |
Columns are period end dates · fundamentals updated 2 Nov 2026